FIELD: biotechnology, genetic engineering. SUBSTANCE: invention relates to polypeptide that is a derivative of the factor that inhibits lipogenesis in human. Polypeptide is produced by recombinant method or by hydrolysis with trypsin. This polypeptide has no from 1 to 9 N-terminal amino acids. Method involves preparing AGIF-containing expressing vector used for transformation of host-cells. Host-cells are cultured under conditions of expression of indicated derivative AGIF and the latter is isolated from culture. Fused protein has AGIF with deletion from 1 to 9 N-terminal amino acids and fused with protein that binds maltose. Then method involves the construction of the expression vector containing DNA sequence encoding the fused protein and used its for transformation of corresponding host-cells followed by culturing host-cells under conditions for expression of the indicated fused protein. Culture is treated with an enzyme that is able to split the expressed fused protein at the specific site and the end product is isolated from the culture. Invention ensures to obtain an inhibitor of differentiation of adipocytes and new polypeptides exhibiting activity of the matured AGIF. EFFECT: improved method of producing. 12 cl, 6 dwg, 4 ex
Title |
Year |
Author |
Number |
POLYNUCLEOTIDE SEQUENCE (VARIANTS), POLYPEPTIDE (VARIANTS), FUSED PROTEIN, PHARMACEUTICAL COMPOSITION, MONOCLONAL ANTIBODY, STRAIN OF HYBRID CULTURED CELLS |
1995 |
- Tokhru Takakhasi
- Rjuta Koisi
- Itiro Kavasima
- Nobufuza Serizava
|
RU2143491C1 |
RECOMBINANT PROTEIN-FACTOR OF INHIBITION OF LIPOGENESIS, DNA ENCODING THEREOF, EXPRESSION VECTOR, RECOMBINANT MAMMALIAN STRAIN OF CELLS COS-1 AS PRODUCER OF LIPOGENESIS INHIBITORY FACTOR, METHOD OF ITS PRODUCING AND COMPOSITION SHOWING ACTIVITY OF LIPOGENESIS INHIBITION |
1991 |
- Itiro Kavasima
- Dzan Okhsumi
- Kendzi Mijadaj
- Jo Takiguti
|
RU2158307C2 |
DNA FRAGMENT, METHOD OF PRAVASTATIN SODIUM PREPARING, EXPRESSION PLASMID (VARIANTS), RECOMBINANT STRAIN (VARIANTS) |
1996 |
- Nobufusa Serizava
- Itiro Vatanabe
|
RU2140984C1 |
ANTIBODY AGAINST INTERFERON-ALPHA/BETA-CONNECTING PROTEIN II (IFNAB-BPII) |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2362781C2 |
ANTIBODY AGAINST INTERFERON-α/β-BINDING PROTEIN I (IFNAB-BPI) |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2363705C2 |
SYSTEM FOR ERADICATION OF VEGETABLE CELLS |
2001 |
- Tomas Kristofer Dzhon Robert
- Makferson Majkl Dzhon
- Atkinson Khauard Dzhon
- Nilehm Ehnil
|
RU2285045C2 |
NOVEL PROTEINS AND METHODS OF THEIR PREPARING |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2194714C2 |
PROTEIN IFNAB-BPII ELICITING ABILITY TO BIND INTERFERON-α/β, ITS PRECURSOR AND FUSION PROTEINS, METHOD FOR PREPARING IFNAB-BPII, DNA MOLECULES, EXPRESSING VECTOR, PHARMACEUTICAL COMPOSITION |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2232811C2 |
ANTIBODY AGAINST TUMOR-SPECIFIC ANTIGENS AS TARGET |
2004 |
- Itikava Kimikhisa
- Takakhasi Su
- Agatsuma Tosinori
- Fukuti Kejsuke
- Khirai Takekhiro
|
RU2345090C2 |
POLYNUCLEOTIDE ELICITING ABILITY TO ACCELERATE BIOSYNTHESIS OF PRAVASTATIN PRECURSOR ML-236B (VARIANTS), PLASMID EXPRESSION VECTOR, STRAIN PENICILLIUM CITRINUM (VARIANTS), STRAIN ESCHERICHIA COLI (VARIANTS), POLYPEPTIDE ACCELERATING BIOSYNTHESIS OF ML-236B (VARIANTS), PRAVASTATIN PRECURSOR ML-236B, METHOD FOR PREPARING PRAVASTATIN |
2001 |
- Esikava Khirodzi
- Abe Juki
- Ono Tikho
|
RU2236463C2 |